<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00728559</url>
  </required_header>
  <id_info>
    <org_study_id>lapmar1.CTIL</org_study_id>
    <nct_id>NCT00728559</nct_id>
  </id_info>
  <brief_title>Evaluation of Local Anlagesia Into the Trocar Site During Operative Laparosocpy</brief_title>
  <official_title>Evaluation of Local Anlagesia Into the Trocar Site During Operative Laparosocpy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Baruch Padeh Medical Center, Poriya</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Israel</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Baruch Padeh Medical Center, Poriya</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the literature there is conflicting data on administration of local analgesia in addition
      to the general anesthesia to the trocar sites during laparoscopy, We believe that adding
      local analgesia to the general anesthesia during laparoscopy is beneficial . the current
      study will evaluate prospectivly the impact of local analgesia on postoperative pain and
      recovery in patients undergoing operative laparoscopy
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Methods: this is a blinded prospective randomized study. After approval of IRB and informed
      consent 120 patients undergoing for laparoscopy will be randomized after the induction of
      general anesthesia into three groups: Group A will receive preemptive analgesia using 3-5 cc
      of 0,5 % marcaine at the beginning of the procedure. Group 2 will receive a local analgesia
      using 3-5 cc marcaine at the end of the procedure. Group 3 will be operated under general
      anesthesia only. The post operative pain and patient recovery will be assessed by the nurses
      during the hospitalization using a VAS (Visual Analog Scale) the total analgetic drugs will
      be noted and after the patients discharge the patient status and satisfaction will be
      evaluated by phone up to 2 wks
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain measured by VAS</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>total analgesics required, patient recovery, patient satisfaction</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>preemptive trocar site analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>trocar site pre skin closure analgesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>control</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>bupivacain 0.5%</intervention_name>
    <description>trocar site injection</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <other_name>marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female older then 18 y/o

        Exclusion Criteria:

          -  Allergy to marcaine
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ilan Atlas, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Ministry of Health, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ilan atlas, md</last_name>
    <phone>011972506267421</phone>
    <email>ilanatlas@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>samer tannus, md</last_name>
    <phone>01197249540410</phone>
    <email>stannus@bezeqint.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Poria Gov Hospital</name>
      <address>
        <city>Tiberias</city>
        <state>Lower Galilee</state>
        <zip>15208</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>ilan Atlas, MD</last_name>
      <phone>01197249080914</phone>
      <email>ilanatlas@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Samer Tannus, MD</last_name>
      <phone>01197246652565</phone>
      <email>stannus@bezeqint.co.il</email>
    </contact_backup>
    <investigator>
      <last_name>Ilan Atlas, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 1, 2008</study_first_submitted>
  <study_first_submitted_qc>August 5, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 6, 2008</study_first_posted>
  <last_update_submitted>February 2, 2011</last_update_submitted>
  <last_update_submitted_qc>February 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 3, 2011</last_update_posted>
  <responsible_party>
    <name_title>Ilan Atlas, MD Gynecologic Oncology Director</name_title>
    <organization>Poria Medical Center</organization>
  </responsible_party>
  <keyword>laparoscopy</keyword>
  <keyword>preemptive</keyword>
  <keyword>postoperative</keyword>
  <keyword>pain</keyword>
  <keyword>trocar</keyword>
  <keyword>site</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

